Representation from India in multinational, interventional, phase 2 or 3 trials registered in Clinical Trials Registry-India: A cross-sectional study

Representation from India in multinational, interventional, phase 2 or 3 trials registered in Clinical Trials Registry-India: A cross-sectional study

Show other versions (1)

Bibliographic Details
Main Authors:	Jaishree Mendiratta, Ravi N. Vaswani, Gayatri Saberwal
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511072/?tool=EBI

Similar Items

Representation from India in multinational, interventional, phase 2 or 3 trials registered in Clinical Trials Registry-India: A cross-sectional study.
by: Jaishree Mendiratta, et al.
Published: (2023-01-01)

An analysis of deficiencies in the ethics committee data of certain interventional trials registered with the Clinical Trials Registry-India.
by: Indraneel Chakraborty, et al.
Published: (2022-01-01)

An analysis of deficiencies in the ethics committee data of certain interventional trials registered with the Clinical Trials Registry–India
by: Indraneel Chakraborty, et al.
Published: (2022-01-01)

Identifying trials run in India that are registered in other clinical trial registries: a cross-sectional study
by: Rishima Borah, et al.
Published: (2024-09-01)

Ethnic representation in interventional clinical trials run in India
by: Jaishree Mendiratta, et al.
Published: (2023-08-01)

An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India
by: Mounika Pillamarapu, et al.
Published: (2019-08-01)

Response to the Letter on: “An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry – India”
by: Mounika Pillamarapu, et al.
Published: (2020-01-01)

Clinical trial registration in India: 12% of drug regulatory trials are not registered, as required by law
by: Adithi Gopadi Ravindranath, et al.
Published: (2025-02-01)

Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match
by: Iqbal S. Bhalla, et al.
Published: (2024-02-01)

Three levels of discrepancies in the records of trial sites in India, registered with the European Union Clinical Trials Register
by: Anwesha Dhal Samanta, et al.
Published: (2024-07-01)

Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law.
by: Sangeeta Kumari, et al.
Published: (2020-01-01)

Data from the Indian drug regulator and from Clinical Trials Registry-India does not always match
by: Bhalla, IS, et al.
Published: (2024)

The need for a new keyword — “Trial registry-metaresearch” — to track certain uses of clinical trial registry records
by: Gayatri Saberwal
Published: (2023-03-01)

In India, most principal investigators have run very few trials over the years
by: Rishima Borah, et al.
Published: (2024-08-01)

Letter on: “An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry – India”
by: Mohua Maulik, et al.
Published: (2020-01-01)

An audit of medical postgraduate theses registered in the Clinical Trials Registry of India in 2019
by: Shruti V Tilak, et al.
Published: (2023-01-01)

A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one.
by: Nisha Venugopal, et al.
Published: (2021-01-01)

Analysis of ayurvedic clinical trials registered in clinical trials registry of india: retrospective versus prospective registration
by: Pravin M Bolshete
Published: (2017-01-01)

An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov.
by: Shruthi Muralidharan Keezhupalat, et al.
Published: (2016-01-01)

Rare disease patients in India are rarely involved in international orphan drug trials
by: Monoswi Chakraborty, et al.
Published: (2022-01-01)

Rare disease patients in India are rarely involved in international orphan drug trials.
by: Monoswi Chakraborty, et al.
Published: (2022-01-01)

An audit of clinical studies involving elderly population registered in clinical trials registry of India
by: Avi Anil Sharma, et al.
Published: (2021-01-01)

Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020
by: M.S. Shree Devi, et al.
Published: (2021-04-01)

Challenges in launching multinational oncology clinical trials in India.
by: Saini, K, et al.
Published: (2013)

Terminated Interventional Trials in the Clinical Trial Registry of India Database: An Analysis to Evaluate the Reasons for Termination
by: Dutta S, et al.
Published: (2020-12-01)

Clinical trials in dentistry in India: Analysis from trial registry
by: S Gowri, et al.
Published: (2017-01-01)

Clinical trials in Ayurveda: Analysis of clinical trial registry of India
by: Kannan Sridharan, et al.
Published: (2016-07-01)

Publication of studies registered in Clinical Trials Registry of India: An audit of mood disorder research protocols from 2009-2019
by: Vikas Menon, et al.
Published: (2023-01-01)

The role of patient organizations in the rare disease ecosystem in India: an interview based study
by: Mohua Chakraborty Choudhury, et al.
Published: (2019-05-01)

Do clinical trials conducted in India match its healthcare needs? An audit of the Clinical Trials Registry of India
by: Mansi Chaturvedi, et al.
Published: (2017-01-01)

Changing landscape of geriatric clinical trials: Analysis of Clinical Trials Registry of India
by: Abissha Sargunaraj, et al.
Published: (2024-10-01)

The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study
by: Mohua Chakraborty Choudhury, et al.
Published: (2019-11-01)

Publication bias in trials registered in the Australian New Zealand Clinical Trials Registry: Is it a problem? A cross-sectional study.
by: Marian Showell, et al.
Published: (2023-01-01)

Publication bias in trials registered in the Australian New Zealand Clinical Trials Registry: Is it a problem? A cross-sectional study
by: Marian Showell, et al.
Published: (2023-01-01)

Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data.
by: Mohua Chakraborty Choudhury, et al.
Published: (2022-01-01)

Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data
by: Mohua Chakraborty Choudhury, et al.
Published: (2022-01-01)

A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials
by: Sowparnika Treasa Sabu, et al.
Published: (2024-01-01)

Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study
by: DeVito, NJ, et al.
Published: (2024)

Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study
by: Ben Goldacre, et al.
Published: (2024-08-01)

Characteristics of Clinical Trials in Iran: A Sample of 5000 Trials Registered in Iranian Registry of Clinical Trials (IRCT)
by: F Fakhri, et al.
Published: (2019-05-01)